- Adjusted operating profit was GBP146.9 million, slightly below the estimated GBP149.4 million.
- Consumer Care adjusted profit came in at GBP85.7 million, missing the estimate of GBP88.1 million.
- Life Sciences adjusted profit exceeded projections, reaching GBP56.1 million against an estimate of GBP54.5 million.
- Industrial Specialties adjusted profit was GBP5.1 million, less than the expected GBP6.46 million.
- Total sales were reported at GBP855.8 million, marginally surpassing the estimate of GBP855.3 million.
- Consumer Care sales reached GBP491.8 million, slightly above the forecasted GBP490.6 million.
- Life Sciences sales amounted to GBP261.0 million, just below the expected GBP264.2 million.
- Industrial Specialties sales were GBP103.0 million, near the estimate of GBP103.1 million.
- Adjusted pretax profit matched closer to expectations at GBP138.0 million, with an estimate of GBP138.2 million.
- Pretax profit was significantly lower at GBP85.5 million compared to the anticipated GBP114.9 million.
- Market experts issued 7 “buy” ratings, 6 “hold” ratings, and 2 “sell” ratings.
A look at Croda International Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts are divided on the long-term outlook for Croda International, with a mixed bag of Smart Scores indicating various aspects of the company’s performance. With a solid score in Dividend at 4, investors can expect a decent return in the form of dividends. However, the Growth and Momentum scores are comparatively lower at 2, suggesting a slower growth trajectory and weaker market momentum in the near future. The Value and Resilience scores stand at 3, pointing towards moderate indicators in these areas.
Croda International plc, known for its diverse range of chemicals and chemical products, caters to a wide array of industries ranging from personal care to automotive. While the company has a good track record in paying dividends, the lower scores in Growth and Momentum may indicate challenges in accelerating its growth and market performance. Investors should keep a close watch on how Croda navigates these factors to improve its overall outlook in the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
